BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-932@pharmaconomics
DTSTAMP:20260707T033835Z
DTSTART;VALUE=DATE:20260623
DTEND;VALUE=DATE:20260624
SUMMARY:QNRX Approval — QYLEKI
DESCRIPTION:A final FDA approval decision on QYLEKI for Netherton Syndrome is expected Jun 23\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1671502/000110465926076822/tm2618505d1_8k.htm\n\nTrack it: https://pharmaconomics.com/e/932
URL:https://pharmaconomics.com/e/932
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:QNRX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR